Загрузка...
Fibrinolytics for the treatment of pulmonary embolism
The use of fibrinolytic agents in acute PE, first described over 50 years ago, hastens the resolution of RV stain, leading to earlier hemodynamic improvement. However, this benefit comes at the increased risk of bleeding. The strongest indication for fibrinolysis is in high-risk PE, or that characte...
Сохранить в:
| Опубликовано в: : | Transl Res |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7487055/ https://ncbi.nlm.nih.gov/pubmed/32434005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2020.05.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|